In the BioHarmony Drug Report Database

"Preview" Icon

Aliskiren

Tekturna, Rasilez (aliskiren) is a small molecule pharmaceutical. Aliskiren was first approved as Tekturna on 2007-03-05. It is used to treat hypertension in the USA. It has been approved in Europe to treat hypertension. The pharmaceutical is active against renin. Tekturna’s patent is valid until 2026-02-19 (FDA).

 

Trade Name

 

Rasilez
 

Common Name

 

aliskiren
 

ChEMBL ID

 

CHEMBL1639
 

Indication

 

hypertension
 

Drug Class

 

Renin inhibitors

Image (chem structure or protein)

Aliskiren structure rendering